WallStreetZenWallStreetZen

NASDAQ: ELEV
Elevation Oncology Inc Stock Ownership - Who owns Elevation Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Elevation Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2025-06-164,627$0.39
$1.78kSell
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2025-05-152,303$0.30
$690.90Sell
Tammy FurlongCHIEF FINANCIAL OFFICER2025-05-15784$0.30
$235.20Sell
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2025-03-164,628$0.53
$2.47kSell
Valerie Malyvanh JansenCHIEF MEDICAL OFFICER2025-02-155,189$0.67
$3.49kSell
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2025-02-159,211$0.67
$6.19kSell
Tammy FurlongCHIEF FINANCIAL OFFICER2025-02-152,780$0.67
$1.87kSell
Tammy FurlongCHIEF FINANCIAL OFFICER2025-02-1589$0.67
$59.81Sell
David DornanCHIEF SCIENTIFIC OFFICER2025-02-154,152$0.67
$2.79kSell
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2024-12-164,629$0.64
$2.96kSell

1 of 2

ELEV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELEV insiders and whales buy or sell their stock.

ELEV Shareholders

What type of owners hold Elevation Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP10.12%5,993,579$2.25MInstitution
Bml Capital Management LLC9.95%5,890,934$2.21MInstitution
Tang Capital Management LLC8.04%4,760,000$1.79MInstitution
Blackrock Inc5.37%3,177,903$1.19MInstitution
Aisling Capital IV LP4.79%2,834,910$1.06MInsider
Aisling Capital Management LP4.79%2,834,910$1.06MInstitution
Vanguard Group Inc4.37%2,585,220$969.46kInstitution
Qiming Us Healthcare Fund II LP4.00%2,370,142$888.80kInsider
Vertex Global Hc Fund II Pte Ltd3.90%2,307,642$865.37kInsider
Cormorant Asset Management LP3.77%2,233,168$837.44kInsider

1 of 3

ELEV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELEV57.15%20.04%Net SellingNet Selling
CVKD0.92%99.08%
DARE3.13%96.87%
CING1.74%98.26%Net Selling
SLGL100.00%0.00%
View Top Biotech Stocks

Elevation Oncology Stock Ownership FAQ

Who owns Elevation Oncology?

Elevation Oncology (NASDAQ: ELEV) is owned by 57.15% institutional shareholders, 20.04% Elevation Oncology insiders, and 22.80% retail investors. Aisling Capital IV LP is the largest individual Elevation Oncology shareholder, owning 2.83M shares representing 4.79% of the company. Aisling Capital IV LP's Elevation Oncology shares are currently valued at $1.06M.

If you're new to stock investing, here's how to buy Elevation Oncology stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.